2020 China Drug Evaluation Report – Part 4
Part 4. On-site/Distant Inspection and Advisory Meetings Table of contents 1. Drug GMP Inspection. 1.1.On-site Inspection. 1.2. Distant Inspection. 2 CDE Advisory Meetings and Communications. 2.1. Overview. 2.2. CDE Advisory Meetings. 2.3. Fast-track Review Meetings. 2.4. Technical Issue Communications. Drug review and approval challenges in 2020 included overcoming difficulties in completing facility inspection, conducting…